JAMES MICHAEL PLUDA
Medical Practice in Hatfield, PA

License number
Pennsylvania MD428224
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Hatfield, PA 19440

Professional information

James M Pluda Photo 1

Dr. James M Pluda, Hatfield PA - MD (Doctor of Medicine)

Specialties:
Oncology, Medical Oncology
Address:
1613 Harvest Moon Ln, Hatfield 19440
(215) 361-3456 (Phone)
Certifications:
Internal Medicine, 1983, Medical Oncology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1980
Mayo Clinic-Rochester
Natl Canc Inst


James Pluda Photo 2

Method Of Treating Cancers With Saha And Pemetrexed

US Patent:
2007011, May 24, 2007
Filed:
Nov 3, 2006
Appl. No.:
11/592512
Inventors:
James Pluda - Hatfield PA, US
Stanley Frankel - Yardley PA, US
Victoria Richon - Wellesley MA, US
Steven Averbuch - North Wales PA, US
Judy Chiao - Berkeley Heights NJ, US
International Classification:
A61K 31/519, A61K 31/19
US Classification:
514265100, 514575000
Abstract:
The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.


James Pluda Photo 3

Method Of Treating Cancers With Saha And Pemetrexed

US Patent:
2008026, Oct 30, 2008
Filed:
May 20, 2008
Appl. No.:
12/154089
Inventors:
James Pluda - Hatfield PA, US
Stanley R. Frankel - Yardley PA, US
Victoria M. Richon - Wellesley MA, US
Steven Averbuch - North Wales PA, US
Judy H. Chiao - Berkeley Heights NJ, US
International Classification:
A61K 31/56, A61K 31/519
US Classification:
514180, 5142651
Abstract:
The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.